ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment

ClinicalTrials.gov ID: NCT03597503

Public ClinicalTrials.gov record NCT03597503. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 9, 2026, 12:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Assessment of Efficacy and Safety of SPN-810 for the Treatment of Impulsive Aggression (IA) in Adolescent Subjects With Attention Deficit/Hyperactivity Disorder (ADHD) in Conjunction With Standard ADHD Treatment

Study identification

NCT ID
NCT03597503
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Supernus Pharmaceuticals, Inc.
Industry
Enrollment
41 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • SPN-810 Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 30, 2018
Primary completion
Jan 21, 2020
Completion
Jan 21, 2020
Last update posted
Apr 23, 2024

2018 – 2020

United States locations

U.S. sites
38
U.S. states
17
U.S. cities
36
Facility City State ZIP Site status
ProScience Culver City California 90230
Neuropsychiatric Research Center of Orange County Orange California 92868
MCB Clinical Research Centers, LLC Colorado Springs Colorado 80910
Children's National Medical Center/Children's Research Institute Washington D.C. District of Columbia 20310
Clinical Neuroscience Solutions, Inc Jacksonville Florida 32217
Meridien Research aka Florida Clinical Research Center, LLC Lakeland Florida 33805
Florida Clinical Research Center, LLC. Maitland Florida 32751
Miami Clinical Research Miami Florida 33155
Miami Research Associates South Miami Florida 33143
University of South Florida- Dept. of Psychiatry and Neurosciences Tampa Florida 33613
Atlanta Center for Medical Research Atlanta Georgia 30331
iResearch Atlanta Decatur Georgia 30030
Capstone Clinical Research Libertyville Illinois 60048
AMR Conventions Research Naperville Illinois 60563
Psychiatric Associates Overland Park Kansas 66211
Hugo W Moser Research Institute at Kennedy Krieger Baltimore Maryland 21205
St. Charles Psychiatric Associates Midwest Research Center Saint Charles Missouri 63304
Alivation Research, LLC Lincoln Nebraska 68526
Hassmann Research Institute Berlin New Jersey 08009
Finger Lakes Clinical Research Rochester New York 14618
University of Cincinnati Department of Psychiatry and Behavioral Neuroscience Cincinnati Ohio 45219
Ohio State University Nisonger Center Clinical Trials Program Columbus Ohio 43210
Oklahoma Clinical Research Center Oklahoma City Oklahoma 73112
Paradigm Research Professionals Oklahoma City Oklahoma 73118
CNS Healthcare Memphis Tennessee 38119
Texas Physicians Medical Research Group Arlington Texas 76014
BioBehavioral Research of Austin P.C. Austin Texas 78759
Gaolin Research, LLC Beaumont Texas 77702
Relaro Medical Trials Dallas Texas 75243
InSite Clinical Research DeSoto Texas 75115
Houston Clinical Trials Houston Texas 08009
Dicovery MM Services Inc. Houston Houston Texas 77061
FMCScience Lampasas Texas 76550
Discovery MM Service, Inc. Missouri Missouri City Texas 77459
Clinical Trials of Texas, Inc. San Antonio Texas 78229
Family Psychiatry of the Woodlands The Woodlands Texas 77381
Ericksen Research & Development Clinton Utah 84015
Aspen Clinical Research Orem Utah 84058

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03597503, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2024 · Synced May 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03597503 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →